martes, 6 de agosto de 2019

STAT Plus: Alzheimer’s patients didn’t decline after getting a cocktail derived from young blood, but big questions remain By REBECCA ROBBINS

Daily Recap

STAT Plus: Alzheimer’s patients didn’t decline after getting a cocktail derived from young blood, but big questions remain

By REBECCA ROBBINS

ALKAHEST
Big questions remain about the treatment from Silicon Valley firm Alkahest, but it at least appeared safe in a Phase 2 study.

No hay comentarios: